ProCE Banner Activity

Key Viral Hepatitis Studies Influencing My Practice Following EASL 2022—Audio Recap

Podcast Episodes
Conference Coverage
Listen to expert insights from Stefan Zeuzem, MD, on updates and new viral hepatitis data from EASL 2022, including novel therapeutics for HBV, HBV cure data, therapeutic updates for HDV, and HCV treatment for treatment-experienced patients.

Released: July 06, 2022

Expiration: July 05, 2023

Share

Faculty

Stefan Zeuzem

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Stefan Zeuzem, MD, has disclosed that he has received consulting fees from AbbVie, Gilead Sciences, Intercept, Janssen, Novo Nordisk, and Sobi and fees for non-CME/CE services from AbbVie, Gilead Sciences, and MSD.